The abstract is read at the publisher; the summary is JClub's.
Early discontinuation of empiric antibiotics within 72 hours of febrile neutropenia in CAYA after haploidentical HCT reduced antibiotic exposure by a median 8 days without increasing adverse outcomes.
- Why it matters: Empiric antibiotic duration for febrile neutropenia is uncertain in children, adolescents, and young adults undergoing haploidentical hematopoietic cell transplant, creating a need to balance exposure with safety.
- What they did: In a retrospective quasi-experimental study of CAYA haplo-HCT recipients (2010–2022), investigators compared pre-2017 versus post-2017 guideline implementation, measuring days of therapy and secondary outcomes including bloodstream infections, ICU admission, and mortality.
- The result: Postimplementation patients (n = 82) had fewer days of therapy than preimplementation (n = 90) with P < .01, and DOOR-modified RADAR showed a 70% (95% CI, 61%–78%) probability of more favorable outcomes (P < .01).
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.